compounding semaglutide fda enforcement news today The FDA's Decision to Ban Compounds: What You Need to Know Compounded Semaglutide - Elite Health

Historically, no, but qualifying Medicare beneficiaries can get coverage for Wegovy from July 1, 2026, until December 31, 2027, via the new Medicare GLP-1 Bridge program

It is important to contextualise this risk: obesity itself is an independent risk factor for pancreatitis, as are conditions commonly associated with excess weight such as gallstones, hypertriglyceridaemia, and type 2 diabetes

Medication chosen by your provider Semaglutide (Ozempic/Wegovy) or tirzepatide (Mounjaro/Zepbound) your provider chooses based on your labs, health history, and goals

That said, do not use this as justification for routinely dosing early

What is HbA1c

The alcohol needs to evaporate to be effective as a disinfectant anyway